Ozempic, a GLP-1 drug initially approved for type 2 diabetes, has received FDA approval to help reduce risks associated with chronic kidney disease (CKD). The drug is expected to impact millions of adults living with type 2 diabetes and CKD, aiming to lower the risk of kidney failure and cardiovascular death. The approval is based on a pivotal trial and positions Ozempic as the most broadly indicated GLP-1 RA.
Ozempic, which is the GLP-1 drug initially approved by the U.S. Food and Drug Administration in 2017 to treat type 2 diabetes, was recently OK'd to also help reduce risks linked to chronic kidney disease, or CKD.
"With this new indication, Ozempic stands out uniquely as the most broadly indicated GLP-1 RA in its class," Windle said. "We are proud to continue advancing innovations that will have a meaningful impact for this patient population, underscoring Novo Nordisk's commitment to cardiometabolic care." "This approval, along with its existing indications for adults with type 2 diabetes to improve glycemic control and to reduce the risk of major cardiovascular events in adults also with known heart disease, establishes Ozempic injection 0.5 mg, 1 mg, or 2 mg as the most broadly indicated glucagon-like peptide-1 receptor agonist in its class," the release noted.
Through the years, there has been an increase in demand for Ozempic, or semaglutide, due to its weight loss benefits. The popularity led to shortages in the past.
CHRONIC KIDNEY DISEASE OZEMPIC GLP-1 DIABETES CARDIOVASCULAR HEALTH
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic and Other GLP-1s May Have Broader Health Benefits but Greater RisksLearn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a risk to other vital organs.
Read more »
Ozempic and GLP-1 Drugs: A Spectrum of Benefits and RisksA new study reveals the wide-ranging effects of Ozempic and other GLP-1 drugs, highlighting both their potential to improve health and the associated risks.
Read more »
Christina Aguilera claps back at comments about her looks after Ozempic speculation: 'No one deserves an explanation'Christina Aguilera shows off slim figure in skintight Halloween dress after brushing off Ozempic rumors
Read more »
Florida Teen Loses 150 Pounds on Ozempic: 'I Learned to Accept and Love Myself'Shaelyn Weaver, 19, lost 150 pounds in eight months after struggling with her weight for years. She credits Ozempic, lifestyle changes, and her own determination for the success.
Read more »
Could Ozempic Change Beauty Standards?A PhD student's viral TikTok theory suggests that the accessibility of Ozempic, a weight-loss drug, could shift the beauty ideal from thinness to a new standard, driven by economics.
Read more »
Ricki Lake Sheds 40 Pounds Without OzempicRicki Lake reveals her weight loss journey, emphasizing a healthy lifestyle approach including keto diet, exercise, and stress management.
Read more »